Displaying archives for 2013 September:

Collagen clue reveals new drug target for untreatable form of lung cancer

Posted by Samantha Powell on September 29th, 2013 |

News Headline: Collagen clue reveals new drug target for untreatable form of lung cancer Date: 8/29/13 Outlet Full Name: Medical Xpress Author Name: N/A http://medicalxpress.com/news/2013-08-collagen-clue-reveals-drug-untreatable.html Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from […]

BI personalized NSCLC drug approved in Europe

Posted by Samantha Powell on September 26th, 2013 |

News Headline: BI personalized NSCLC drug approved in Europe Date: 9/26/13 Outlet Full Name: Pharma Times Author Name: Kevin Grogan http://www.pharmatimes.com/Article/13-09-26/BI_personalised_NSCLC_drug_approved_in_Europe.aspx Boehringer Ingelheim has received a boost after getting the green light for its targeted lung cancer drug Giotrif. Specifically, the European Commission has granted marketing authorisation for Giotrif (afatinib) for the treatment of patients […]

Longtime Lung Cancer Research Advocate Mike Stevens Dies

Posted by Samantha Powell on September 26th, 2013 |

News Headline: Longtime Lung Cancer Research Advocate Mike Stevens Dies Date: 9/26/13 Outlet Full Name: NBC San Diego Author Name: R. Stickney http://www.nbcsandiego.com/news/health/Lung-Cancer-Research-Advocate-Mike-Stevens-Dies-San-Diego-225379592.html A San Diegan considered an amazing advocate for those living with lung cancer has died. On Wednesday, the California chapter of the Lung Cancer Alliance shared the news about the death of […]

Understanding the Respiratory System with Lung Cancer

Posted by Samantha Powell on September 25th, 2013 |

News Headline: Understanding the Respiratory System with Lung Cancer Date: 9/25/13 Outlet Full Name: About.com – Lung Cancer Author Name: Lynne Eldridge MD http://lungcancer.about.com/b/2013/09/25/understanding-the-respiratory-system-with-lung-cancer.htm When you’re living with lung cancer you will probably hear many terms – bronchus, bronchi, bronchioles, alveoli, mediastinum, and more. And unless you’ve studied human anatomy, what’s described can be a mystery. At first […]

Myriad Genetics’ myPlan™ Lung Cancer Test Meets Primary Clinical Endpoint

Posted by Samantha Powell on September 25th, 2013 |

Verification Study Published in the Journal Clinical Cancer Research SALT LAKE CITY, Utah, Sept. 24, 2013 – Myriad Genetics, Inc. (NASDAQ: MYGN) today announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and may […]

Study: Married People Survive Cancer Longer Than Singles

Posted by Samantha Powell on September 24th, 2013 |

News Headline: Study: Married People Survive Cancer Longer Than Singles Date: 9/24/13 Outlet Full Name: Forbes Author Name: Alice G. Walton http://www.forbes.com/sites/alicegwalton/2013/09/24/the-marriage-health-connection-extends-to-cancer-survival/ Falling in line with previous work, a new study suggests that married people have better odds of surviving cancer than single – or widowed, separated, or divorced – folk. Not only were the […]

A Dream Come True: Bride With Cancer Receives Fantasy Wedding

Posted by Samantha Powell on September 24th, 2013 |

News Headline: A Dream Come True: Bride With Cancer Receives Fantasy Wedding Date: 9/24/13 Outlet Full Name: Huffington Post Author Name: Diane Forden http://www.huffingtonpost.com/bridal-guide/a-dream-come-true-bride-w_b_3981535.html Last December, San Jose, CA hairstylist, Jen Bulik, received the worst news possible and was diagnosed with stage IV lung cancer. She and her boyfriend of six years, Jeff Lang, a […]

Myriad Genetics’ myPlan™ Lung Cancer Test Meets Primary Clinical Endpoint

mygn-myriad-genetics-logo
Posted by Samantha Powell on September 24th, 2013 |

Myriad Genetics’ myPlan™ Lung Cancer Test Meets Primary Clinical Endpoint Verification Study Published in the Journal Clinical Cancer Research SALT LAKE CITY, Utah, Sept. 24, 2013 – Myriad Genetics, Inc. (NASDAQ: MYGN) today announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer […]

Roche Gets Breakthrough Status for Lung Cancer Drug

Posted by Samantha Powell on September 23rd, 2013 |

News Headline: Roche Gets Breakthrough Status for Lung Cancer Drug Date: 9/23/13 Outlet Full Name: Drug Discovery and Development Author:  No Author http://www.dddmag.com/news/2013/09/roche-gets-breakthrough-status-lung-cancer-drug The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for Roche’s alectinib based on data that will be presented at European Cancer Congress (ECC), according to the company. Despite […]

FDG-PET May Help Predict Lung Cancer Survival

Posted by Samantha Powell on September 23rd, 2013 |

News Headline: FDG-PET May Help Predict Lung Cancer Survival Date: 9/23/13 Outlet Full Name: Cancer Network Author Name: Zach Hartman http://www.cancernetwork.com/lung-cancer/content/article/10165/2158755 Analysis of 18F fluorodeoxyglucose positron emission tomography (FDG-PET) standardized uptake values may be a useful technique for predicting survival in patients with inoperable stage III non–small-cell lung carcinoma (NSCLC), according to a study published […]